Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
J Immunol. 2013 Aug 1;191(3):1006-10. doi: 10.4049/jimmunol.1300489. Epub 2013 Jul 1.
The complement system is a potent component of the innate immune response, promoting inflammation and orchestrating defense against pathogens. However, dysregulation of complement is critical to several autoimmune and inflammatory syndromes. Elevated expression of the proinflammatory cytokine IL-1β is often linked to such diseases. In this study, we reveal the mechanistic link between complement and IL-1β secretion using murine dendritic cells. IL-1β secretion occurs following intracellular caspase-1 activation by inflammasomes. We show that complement elicits secretion of both IL-1β and IL-18 in vitro and in vivo via the NLRP3 inflammasome. This effect depends on the inflammasome components NLRP3 and ASC, as well as caspase-1 activity. Interestingly, sublethal complement membrane attack complex formation, but not the anaphylatoxins C3a and C5a, activated the NLRP3 inflammasome in vivo. These findings provide insight into the molecular processes underlying complement-mediated inflammation and highlight the possibility of targeting IL-1β to control complement-induced disease and pathological inflammation.
补体系统是先天免疫反应的有力组成部分,可促进炎症反应,并协调机体抵御病原体。然而,补体失调与多种自身免疫和炎症综合征密切相关。促炎细胞因子 IL-1β 的表达升高通常与这些疾病相关。在这项研究中,我们使用小鼠树突状细胞揭示了补体与 IL-1β 分泌之间的机制联系。IL-1β 的分泌是通过细胞内半胱天冬酶-1 激活炎性小体发生的。我们表明,补体通过 NLRP3 炎性小体在体外和体内引发 IL-1β 和 IL-18 的分泌。这种效应依赖于炎性小体成分 NLRP3 和 ASC 以及半胱天冬酶-1 的活性。有趣的是,亚致死补体膜攻击复合物的形成,而不是过敏毒素 C3a 和 C5a,在体内激活了 NLRP3 炎性小体。这些发现为补体介导的炎症的分子过程提供了深入了解,并强调了靶向 IL-1β 以控制补体诱导的疾病和病理性炎症的可能性。